The firm retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. Let's try to break down what HALOZYME's beta means in this case. the returns on MARKET and HALOZYME THERAPEUTICS are completely uncorrelated. Although it is important to respect HALOZYME THERAPEUTICS current price history, it is better to be realistic regarding the information on the equity's current price movements. The approach towards determining future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By inspecting HALOZYME THERAPEUTICS technical indicators, you can right now evaluate if the expected return of 0.0% will be sustainable into the future. HALOZYME THERAPEUTICS at this time retains a risk of 0.0%. Please check out HALOZYME THERAPEUTICS coefficient of variation, variance, and the relationship between the downside deviation and standard deviation to decide if HALOZYME THERAPEUTICS will be following its current trending patterns.
HALOZYME Performance
0 of 100
Over the last 90 days HALOZYME THERAPEUTICS INC has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively steady basic indicators, HALOZYME THERAPEUTICS is not utilizing all of its potentials. The current stock price chaos, may contribute to medium-term losses for the stakeholders. ...more
Quick Ratio7.94
Fifty Two Week Low37.15
Fifty Two Week High37.78

HALOZYME THERAPEUTICS Relative Risk vs. Return Landscape

If you would invest (100.00)  in HALOZYME THERAPEUTICS INC on May 11, 2022 and sell it today you would earn a total of  100.00  from holding HALOZYME THERAPEUTICS INC or generate -100.0% return on investment over 90 days. HALOZYME THERAPEUTICS INC is producing return of less than zero assuming 0.0% volatility of returns over the 90 days investment horizon. Simply put, 0% of all stocks have less volatile historical return distribution than HALOZYME THERAPEUTICS, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Daily Expected Return (%)  
       Risk (%)  


Today, many novice investors tend to focus exclusively on investment returns with little concern for HALOZYME THERAPEUTICS's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as HALOZYME THERAPEUTICS INC, and traders can use it to determine the average amount a HALOZYME THERAPEUTICS's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Good Returns
Average Returns
Small Returns
Based on monthly moving average HALOZYME THERAPEUTICS is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of HALOZYME THERAPEUTICS by adding it to a well-diversified portfolio.

Things to note about HALOZYME THERAPEUTICS

Checking the ongoing alerts about HALOZYME THERAPEUTICS for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for HALOZYME THERAPEUTICS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.


Equity Alerts and Improvement Suggestions

HALOZYME THERAPEUTICS is not yet fully synchronised with the market data
HALOZYME THERAPEUTICS has some characteristics of a very speculative penny stock
HALOZYME THERAPEUTICS has high likelihood to experience some financial distress in the next 2 years
Over 96.0% of the company shares are owned by institutions such as pension funds
Check out Trending Equities. Note that the HALOZYME THERAPEUTICS information on this page should be used as a complementary analysis to other HALOZYME THERAPEUTICS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Tools for HALOZYME Stock

When running HALOZYME THERAPEUTICS price analysis, check to measure HALOZYME THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HALOZYME THERAPEUTICS is operating at the current time. Most of HALOZYME THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of HALOZYME THERAPEUTICS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move HALOZYME THERAPEUTICS's price. Additionally, you may evaluate how the addition of HALOZYME THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities